Session Information
2012 Midyear Clinical Meeting
Click here to go to the previous page
Expecting the Unexpected: Treatment of Opiate Dependence in Pregnancy
Track:
Education Sessions (CE)
Program Code: 285-L01
Date: Monday, December 3, 2012
Time: 2:00 PM to 3:30 PM EST
Location:
South Seas J, Level 3, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Sarah Melton, PharmD, BCPP, Clinical Pharmacist, Gatton College of Pharmacy, East Tennessee State University
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Sarah Melton, PharmD, BCPP, Clinical Pharmacist, Gatton College of Pharmacy, East Tennessee State University
Description
This case-based session will prepare pharmacists to provide valuable guidance in developing care plans for opiate dependence in pregnancy.
- Contrast the benefits and disadvantages associated with use of buprenorphine or methadone in pregnant women.
- Discuss the management of intrapartum and postpartum pain in opioid dependent patients.
- Evaluate evidence-based literature regarding treatment of opioid dependency during pregnancy with buprenorphine or methadone.
- Examine the incidence and treatment of neonatal abstinence syndrome associated with buprenorphine and methadone use in pregnancy.
This session is a part of:
This session is a part of: